SKIN Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
72.1M
+11.1%
64.9M
-21.2%
82.4M
+16.6%
70.7M
-9.6%
78.2M
Cost of Revenue
22.8M
+11.3%
20.5M
-30.2%
29.3M
+17.2%
25.0M
-13.9%
29.1M
Gross Profit
49.3M
+11.0%
44.4M
-16.2%
53.0M
+16.2%
45.6M
-7.1%
49.1M
Operating Expenses
45.8M
-1.0%
46.2M
-12.6%
52.9M
+1.9%
51.9M
+0.1%
51.8M
R&D
1.4M
+27.7%
1.1M
-34.4%
1.7M
-1.0%
1.7M
+35.7%
1.3M
SG&A
44.4M
-1.7%
45.1M
-11.8%
51.2M
+2.0%
50.2M
-0.8%
50.6M
Operating Income
3.6M
+298.3%
-1801000
-1211.7%
162.0K
+102.6%
-6242000
-131.2%
-2700000
EBITDA
8.8M
+150.2%
3.5M
-35.9%
5.5M
+151.6%
2.2M
-18.9%
2.7M
Net Income
-2669000
+59.7%
-6630000
+18.2%
-8104000
+26.5%
-11031000
-156.0%
19.7M
EPS (Basic)
$-0.02
+60.0%
$-0.05
+16.7%
$-0.06
+33.3%
$-0.09
-156.3%
$0.16
EPS (Diluted)
$-0.02
+60.0%
$-0.05
+0.0%
$-0.05
+44.4%
$-0.09
-400.0%
$0.03
Shares (Diluted)
129.6M
-1.4%
131.4M
-12.9%
150.9M
+18.9%
126.9M
-9.6%
140.3M
SkinHealth Systems (SKIN) โ€” Financials